Dr. Reddy's Laboratories
DRREDDY •NSE

Dr. Reddy's Laboratories

₹1,352.007.00 (0.52%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
F&O

Performance

Today’s low
1,345.00
Today’s high
1,363.70
52 week low
1,101.00
52 week high
1,414.90
Open price
1,345.00
Previous close
1,345.00
Live volume
17,14,059
Lower circuit
1,216.80
Upper circuit
1,487.20

Fundamentals

Market Cap
₹1,11,722Cr
ROE
7.21%
P/E Ratio(TTM)
40.49
EPS(TTM)
33.06
P/B Ratio
2.88
Dividend Yield
0.60%
Industry P/E
37.65
Book Value
464.93
Debt to Equity
0.19
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
SEP '26
₹8,854Cr
+4.73%
₹913Cr
+109.64%
02.5k5k7.5k10k
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue growthValue
1Y (TTM)-3%
3Y CAGR+11%
Profit growthValue
1Y (TTM)-32%
3Y CAGR-3%

About

Dr. Reddy's Laboratories Limited is a global pharmaceutical company based in Hyderabad, India, driven by the core purpose of 'Good Health Can't Wait'. The company's vision is to accelerate access to affordable and innovative medicines, aiming to serve 1.5 billion patients by the year 2030. Its business portfolio includes Active Pharmaceutical Ingredients (APIs), generic drugs, biosimilars, over-the-counter products, and custom pharmaceutical services. The company follows a dual-track approach, which involves strengthening its core business while also building new value by investing in future growth areas. Its primary markets include the USA, India, Russia & CIS, China, Brazil, and Europe, addressing key health needs in these regions. Through its extensive network and diverse workforce, the company has established a global presence, enabling it to serve patients in 83 countries worldwide.;
CEO/MD
Erez Israeli
Founded in
1984
NSE symbol
DRREDDY
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,777.70
+16.70 (0.95%)
L
    H
    4,22,990.7634.915.06
    ₹4,613.40
    +33.40 (0.73%)
    L
      H
      1,73,603.6982.719.45
      CiplaCIPLA
      ₹1,378.90
      +20.90 (1.54%)
      L
        H
        1,09,628.0438.413.1
        ₹1,681.40
        +21.50 (1.30%)
        L
          H
          95,225.0425.662.51
          Livesquawk •
          HSBC maintains Buy on Dr Reddy's with a target price of ₹1,375, driven by improved Q2 gross margins. Key growth catalysts include Semaglutide supplies resuming in November 2026 alongside Abatacept relaunch and FDA approval.
          Livesquawk •
          Citi maintains Buy on Dr Reddy's with a ₹1,510 target after adjusted EBITDA beat estimates by 40% at ₹16.4bn. Management expects strong H2 momentum with semaglutide on track, leading Citi to raise FY27–29 EPS by up to 11%.
          Livesquawk •
          Dr. Reddy's lowered its FY27 capex guidance to ₹1,600–1,700 crore from ₹1,800 crore. The reduction in capital expenditure is driven by project timing adjustments.
          Livesquawk •
          Dr. Reddy's confirmed its Semaglutide relaunch remains on track for November 2026. The company maintained its FY27 volume guidance of 6 to 7 million pens.
          2026
          23
          Oct
          Quarterly Result
          Release date
          22
          Jul
          Quarterly Result
          Release date

          10
          Jul
          Dividend
          Ex date
          ₹8.00
          per share

          For each share you hold, you will receive ₹8.00
          Dividend amount₹8.00 per share
          Dividend TypeFinal
          Ex Date10 Jul ‘26
          Record Date10 Jul ‘26
          Announcement date12 May ‘26

          12
          May
          Dividend
          Announced
          ₹8.00
          per share

          For each share you hold, you will receive ₹8.00
          Dividend amount₹8.00 per share
          Dividend TypeFinal
          Ex Date10 Jul ‘26
          Record Date10 Jul ‘26
          Announcement date12 May ‘26
          12
          May
          Quarterly & Annual Result
          Release date
          21
          Jan
          Quarterly Result
          Release date
          2025
          24
          Oct
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date

          10
          Jul
          Dividend
          Ex date
          ₹8.00
          per share

          For each share you hold, you will receive ₹8.00
          Dividend amount₹8.00 per share
          Dividend TypeFinal
          Ex Date10 Jul ‘25
          Record Date10 Jul ‘25
          Announcement date9 May ‘25

          9
          May
          Dividend
          Announced
          ₹8.00
          per share

          For each share you hold, you will receive ₹8.00
          Dividend amount₹8.00 per share
          Dividend TypeFinal
          Ex Date10 Jul ‘25
          Record Date10 Jul ‘25
          Announcement date9 May ‘25
          Events calendar
          View upcoming events in other stocks